LAG-3 continues generating heavy buzz as Australia's Immutep locks down new funds
An Australian biotech looking to make its mark on the LAG-3 space has pulled in a new round of funding it hopes can kickstart a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
